SYGNIS AG to raise capital to acquire TGR Biosciences
(WorldNews Germany)

PRESS RELEASE 19 March 2018 SYGNIS AG to raise capital to acquire TGR Biosciences Heidelberg, Germany and Cambridge, UK, 19 March 2018 - SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the launch of a private placement of up to 4.74 million new shares to institutional investors in Europe. The price per share is set to EUR 1.40, based on a weighted average XETRA closing price of the Sygnis AG shares of the last ten trading days. The new shares will be issued excluding pre-emptive rights. Book building will commence immediately. It is anticipated that books will close tomorrow, although the bookrunners reserve the right to close the books at any time. SYGNIS...